187 related articles for article (PubMed ID: 7620221)
1. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer.
Joseph P; Xie T; Xu Y; Jaiswal AK
Oncol Res; 1994; 6(10-11):525-32. PubMed ID: 7620221
[TBL] [Abstract][Full Text] [Related]
2. Lack of NQO1 induction in human tumor cells is not due to changes in the promoter region of the gene.
Begleiter A; Lange L
Int J Oncol; 2002 Apr; 20(4):835-8. PubMed ID: 11894133
[TBL] [Abstract][Full Text] [Related]
3. c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction.
Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2002 Aug; 21(34):5301-12. PubMed ID: 12149651
[TBL] [Abstract][Full Text] [Related]
4. Disruption of c-Fos leads to increased expression of NAD(P)H:quinone oxidoreductase1 and glutathione S-transferase.
Wilkinson J; Radjendirane V; Pfeiffer GR; Jaiswal AK; Clapper ML
Biochem Biophys Res Commun; 1998 Dec; 253(3):855-8. PubMed ID: 9918819
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.
Belinsky M; Jaiswal AK
Cancer Metastasis Rev; 1993 Jun; 12(2):103-17. PubMed ID: 8375015
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
7. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment.
Yao KS; Hageboutros A; Ford P; O'Dwyer PJ
Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.
Bloom D; Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2002 Mar; 21(14):2191-200. PubMed ID: 11948402
[TBL] [Abstract][Full Text] [Related]
9. Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression.
Jaiswal AK
Pharmacogenetics; 1994 Feb; 4(1):1-10. PubMed ID: 8004128
[TBL] [Abstract][Full Text] [Related]
10. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
Gasdaska PY; Fisher H; Powis G
Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
[TBL] [Abstract][Full Text] [Related]
11. Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents.
Li Y; Jaiswal AK
Eur J Biochem; 1994 Nov; 226(1):31-9. PubMed ID: 7957257
[TBL] [Abstract][Full Text] [Related]
12. Regulation of genes encoding NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Free Radic Biol Med; 2000 Aug; 29(3-4):254-62. PubMed ID: 11035254
[TBL] [Abstract][Full Text] [Related]
13. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.
Venugopal R; Jaiswal AK
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14960-5. PubMed ID: 8962164
[TBL] [Abstract][Full Text] [Related]
14. ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants.
Xie T; Belinsky M; Xu Y; Jaiswal AK
J Biol Chem; 1995 Mar; 270(12):6894-900. PubMed ID: 7896838
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction.
Wang W; Jaiswal AK
Free Radic Biol Med; 2006 Apr; 40(7):1119-30. PubMed ID: 16545679
[TBL] [Abstract][Full Text] [Related]
16. AP-2-mediated regulation of human NAD(P)H: quinone oxidoreductase 1 (NQO1) gene expression.
Xie T; Jaiswal AK
Biochem Pharmacol; 1996 Mar; 51(6):771-8. PubMed ID: 8602872
[TBL] [Abstract][Full Text] [Related]
17. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.
Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2001 Jun; 20(29):3906-17. PubMed ID: 11439354
[TBL] [Abstract][Full Text] [Related]
19. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C.
Hu LT; Stamberg J; Pan S
Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865
[TBL] [Abstract][Full Text] [Related]
20. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.
Mohora M
Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
